Analyst Faisal Khurshid of Leerink Partners maintained a Hold rating on Ironwood Pharma (IRWD – Research Report), retaining the price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback